Loading company…
MoldCo offers testing and products intended to address mold-related health concerns.
Founded in 2023, MoldCo offers biomarker testing, binders, nasal biofilm disruptors and peptides for people experiencing symptoms associated with mold toxicity. Its services include solutions provided by mold-trained and certified clinicians. The company is based in Boston, US. In September 2025, it raised USD 8 million in seed funding co-led by Cantos Ventures and Collaborative Fund, with other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in